IndraLab

Statements

USP14 inhibits hypersensitivity reaction disease. 1 / 1

| 1

eidos

"We further demonstrate that USP14 inhibition can be therapeutically exploited to enhance sensitivity and to overcome resistance to conventional chemotherapeutic agents for treating NB ."

30962318

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP14 inhibits hypersensitivity reaction disease. 1 / 1

INDRA sources:

Databases

Reading